
Myriad Genetics MYGN
€ 4.09
-0.21%
Geschäftsbericht 2025
hinzugefügt 24.02.2026
Myriad Genetics ROE 2011-2026 | MYGN
ROE Jährlich Myriad Genetics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -99.43 | -18.16 | -33.62 | -12.64 | -2.81 | -6.03 | 0.42 | 13.59 | 2.8 | 16.75 | 12.11 | 24.51 | 20.19 | 17.64 | 17.77 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 24.51 | -99.43 | -3.13 |
ROE Vierteljährlich Myriad Genetics
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -98.55 | -96.16 | -11.4 | -20.37 | -26.32 | -37.15 | -31.31 | -35.14 | -30.0 | -15.7 | -7.48 | -4.94 | 1.43 | 2.4 | -2.49 | -6.8 | -11.06 | -16.83 | -14.04 | -10.51 | -9.56 | -4.03 | -4.2 | -3.18 | -2.17 | -1.14 | 0.69 | 3.82 | 12.63 | 16.54 | 27.03 | 24.48 | 15.34 | 11.96 | 1.37 | 5.36 | 9.86 | 13.64 | 17.82 | 16.46 | 14.3 | 13.06 | 11.27 | 15.26 | 21.05 | 24.62 | 30.01 | 27.85 | 24.56 | 23.16 | 20.28 | 19.58 | 19.17 | 18.66 | 18.34 | 4.33 | 4.99 | 4.43 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 30.01 | -98.55 | -0.08 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Trinity Biotech plc
TRIB
|
287.88 | $ 0.65 | -1.84 % | $ 61.9 M | ||
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Agilent Technologies
A
|
22.45 | $ 115.55 | 1.0 % | $ 35.1 B | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
-227.33 | $ 1.67 | -2.34 % | $ 2.22 M | ||
|
Castle Biosciences
CSTL
|
4.0 | $ 24.46 | 3.25 % | $ 679 M | ||
|
CareDx, Inc
CDNA
|
-7.05 | $ 21.23 | 5.83 % | $ 1.13 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
21.43 | $ 84.33 | 1.82 % | $ 5.69 B | ||
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 16.31 | 1.75 % | $ 493 M | ||
|
Medpace Holdings
MEDP
|
98.27 | $ 410.54 | 4.35 % | $ 11.8 B | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
-4.56 | $ 169.8 | 1.23 % | $ 8.42 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
Guardant Health
GH
|
419.18 | $ 88.91 | 1.18 % | $ 11.1 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
109.89 | $ 1.98 | -2.37 % | $ 8.76 M | ||
|
Illumina
ILMN
|
-51.54 | $ 127.88 | 1.95 % | $ 20.3 B | ||
|
National Research Corporation
NRC
|
82.92 | $ 17.23 | -0.12 % | $ 386 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.97 | $ 27.47 | -0.58 % | $ 20 B | ||
|
Personalis
PSNL
|
-40.05 | $ 6.1 | 3.39 % | $ 361 M | ||
|
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
-121.14 | $ 2.14 | -0.47 % | $ 4.92 M | ||
|
ICON Public Limited Company
ICLR
|
8.31 | $ 102.17 | -3.92 % | $ 8.43 B | ||
|
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 263.8 | -0.43 % | $ 21.9 B | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
Celcuity
CELC
|
-176.06 | $ 121.03 | 6.58 % | $ 5.66 B | ||
|
Thermo Fisher Scientific
TMO
|
12.55 | $ 469.71 | 0.64 % | $ 177 B | ||
|
NeoGenomics
NEO
|
-12.91 | $ 8.29 | 4.8 % | $ 1.06 B | ||
|
Neogen Corporation
NEOG
|
-52.72 | $ 9.54 | 2.03 % | $ 2.07 B | ||
|
Twist Bioscience Corporation
TWST
|
-16.42 | $ 60.94 | 3.55 % | $ 3.64 B | ||
|
Natera
NTRA
|
-77.62 | $ 203.75 | 1.3 % | $ 20.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 196.27 | -1.66 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | ||
|
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | ||
|
Waters Corporation
WAT
|
25.09 | $ 309.87 | -0.43 % | $ 18.5 B |